Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial.
Zülke AE, Pabst A, Luppa M, Roehr S, Seidling H, Oey A, Cardona MI, Blotenberg I, Bauer A, Weise S, Zöllinger I, Sanftenberg L, Brettschneider C, Döhring J, Lunden L, Czock D, Haefeli WE, Wiese B, Hoffmann W, Frese T, Gensichen J, König HH, Kaduszkiewicz H, Thyrian JR, Riedel-Heller SG. Zülke AE, et al. Among authors: lunden l. Alzheimers Dement. 2024 Jan;20(1):615-628. doi: 10.1002/alz.13486. Epub 2023 Sep 28. Alzheimers Dement. 2024. PMID: 37768074 Free PMC article. Clinical Trial.
Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial.
Wittmann FG, Pabst A, Zülke A, Luppa M, Blotenberg I, Cardona MI, Bauer A, Fuchs S, Zöllinger I, Sanftenberg L, Brettschneider C, Döhring J, Lunden L, Czock D, Wiese B, Thyrian JR, Hoffmann W, Frese T, Gensichen J, König HH, Kaduszkiewicz H, Riedel-Heller SG. Wittmann FG, et al. Among authors: lunden l. J Prev Alzheimers Dis. 2024;11(2):348-355. doi: 10.14283/jpad.2024.13. J Prev Alzheimers Dis. 2024. PMID: 38374741 Clinical Trial.
Factors Associated with Lower Social Activity in German Older Adults at Increased Risk of Dementia: A Cross-Sectional Analysis.
Buchholz M, Zöllinger I, Thyrian JR, Luppa M, Zülke A, Döhring J, Lunden L, Sanftenberg L, Brettschneider C, Czock D, Frese T, Gensichen J, Hoffmann W, Kaduszkiewicz H, König HH, Wiese B, Riedel-Heller SG, Blotenberg I. Buchholz M, et al. Among authors: lunden l. J Alzheimers Dis. 2024;98(4):1443-1455. doi: 10.3233/JAD-231226. J Alzheimers Dis. 2024. PMID: 38607756
Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) - protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb).
Tengelmann C, Joos S, Kaußner Y, Malzahn U, Lunden L, Klug A, Häusler KG, Escales C, Maetzler W, Hügen K, Zolk O, Heuschmann PU, Förster C, Kaduszkiewicz H, Gágyor I. Tengelmann C, et al. Among authors: lunden l. BMC Infect Dis. 2024 Jan 6;24(1):56. doi: 10.1186/s12879-023-08925-2. BMC Infect Dis. 2024. PMID: 38184567 Free PMC article.
Exonic mutations in SCN9A (NaV1.7) are found in a minority of patients with erythromelalgia.
Zhang Z, Schmelz M, Segerdahl M, Quiding H, Centerholt C, Juréus A, Carr TH, Whiteley J, Salter H, Kvernebo MS, Ørstavik K, Helås T, Kleggetveit IP, Lunden LK, Jørum E. Zhang Z, et al. Among authors: lunden lk. Scand J Pain. 2014 Oct 1;5(4):217-225. doi: 10.1016/j.sjpain.2014.09.002. Scand J Pain. 2014. PMID: 29911575 Free article.
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing.
Kist AM, Sagafos D, Rush AM, Neacsu C, Eberhardt E, Schmidt R, Lunden LK, Ørstavik K, Kaluza L, Meents J, Zhang Z, Carr TH, Salter H, Malinowsky D, Wollberg P, Krupp J, Kleggetveit IP, Schmelz M, Jørum E, Lampert A, Namer B. Kist AM, et al. Among authors: lunden lk. PLoS One. 2016 Sep 6;11(9):e0161789. doi: 10.1371/journal.pone.0161789. eCollection 2016. PLoS One. 2016. PMID: 27598514 Free PMC article.
14 results